Live updates from opening day 

MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. 

Turn Up Your Support

Health

U.S. health officials say patients taking anti-depressants should be closely monitored for signs of suicidal thoughts. 
The Food and Drug Administration stressed that it's still not clear if there's a connection between anti-depressants and suicide, but this week it called on drug makers to put stronger warnings on their labels. The drugs under scrutiny are all newer-generation anti-depressants, including Prozac, Paxil, Zoloft, and Wellbutrin. Dr. Jon Hallberg, medical director of the Primary Care Clinic at the U of M, says the news isn't entirely new. But it does reinforce the notion that doctors and manufacturers need to give patients more information about the drugs they're taking.

FDA action highlights the risks of anti-depressants

Go Deeper.

Like this?

News you can use in your inbox